Acorda therapeutics, inc. (ACOR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Revenues:
Milestone revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,664

5,516

-

-

-

-

-

25,000

-

-

-

0

-

-

-

-

Gross product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,443

17,254

14,463

14,753

Less: discounts and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,965

1,864

1,606

2,204

Total net revenues

28,099

50,496

47,722

50,053

44,137

69,152

142,814

153,302

106,165

188,398

141,065

139,438

119,386

140,626

135,613

127,458

115,904

130,903

148,199

113,707

99,851

117,872

105,961

97,129

80,518

92,593

84,919

87,053

71,865

81,473

77,437

75,656

71,248

72,644

93,031

65,276

61,286

66,801

63,622

42,835

17,747

15,214

12,549

Costs and expenses:
Cost of sales

3,843

8,667

7,986

9,397

8,799

21,476

25,152

30,378

20,634

26,482

29,992

29,665

25,183

30,210

27,644

26,435

23,186

26,402

24,741

22,708

18,446

24,978

20,575

18,899

15,529

18,377

17,213

16,935

13,484

16,206

14,761

13,576

12,464

13,434

26,651

12,048

12,050

12,944

11,666

7,832

3,076

2,602

2,951

Cost of milestone and license revenue

-

-

-

-

-

-

-

-

-

157

159

159

159

157

159

159

159

157

159

159

159

157

159

159

159

157

159

159

159

158

159

158

159

158

1,908

159

159

-

165

-

-

-

-

Research and development

7,705

9,023

16,073

18,959

16,028

27,058

22,855

25,910

30,560

35,142

33,286

51,184

46,493

53,797

54,777

50,293

44,570

43,988

43,356

31,229

30,636

25,922

16,578

16,448

14,522

14,302

13,839

13,216

12,520

18,191

12,031

12,634

11,025

10,304

9,088

12,008

10,708

7,972

7,970

6,596

8,062

8,197

7,867

Selling, general and administrative

41,108

41,224

48,702

50,195

52,725

36,819

43,571

44,263

47,601

39,520

40,741

49,334

52,024

59,048

54,805

62,604

58,980

52,986

51,056

52,819

48,769

56,457

47,820

50,644

46,892

47,008

42,336

48,003

48,198

45,594

40,121

44,230

38,745

35,721

34,718

40,141

37,928

41,273

30,558

34,112

26,714

23,415

23,925

Goodwill impairment

-

-

277,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

7,691

7,689

7,692

7,691

2,564

-1

239

716

716

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment

4,131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

26,528

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment

-

-

-

-

-

-

-

-

-

-

39,446

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of acquired contingent consideration

-3,682

-30,593

-50,942

-12,800

7,400

33,100

22,700

-7,000

6,200

24,100

-400

6,400

10,800

-3,300

3,700

2,000

6,200

3,500

3,200

1,100

3,100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

34,268

36,010

307,072

73,442

87,516

118,452

114,517

94,267

105,711

406,476

143,224

136,742

134,659

139,912

141,085

141,491

133,095

127,033

122,512

108,015

101,110

116,705

85,132

86,150

77,102

79,844

73,547

78,313

74,361

80,149

67,072

70,598

62,393

59,617

72,365

64,356

60,845

62,684

50,359

48,540

37,852

34,214

34,744

Operating loss

-6,169

14,486

-259,350

-23,389

-43,379

-49,300

28,297

59,035

454

-218,078

-2,159

2,696

-15,273

714

-5,472

-14,033

-17,191

3,870

25,687

5,692

-1,259

1,167

20,829

10,979

3,416

12,749

11,372

8,740

-2,496

1,324

10,365

5,058

8,855

13,027

20,666

920

441

4,117

13,263

-5,705

-20,105

-19,000

-22,195

Other (expense) income, net:
Interest and amortization of debt discount expense

7,566

5,570

4,500

5,378

6,424

5,271

5,415

5,414

5,497

4,881

4,180

5,460

4,143

4,367

4,404

4,033

3,723

3,374

4,037

4,010

4,051

4,173

4,597

426

92

286

544

749

591

385

373

356

766

211

947

1,276

1,136

570

944

1,194

1,214

704

1,507

Interest income

312

843

333

1,498

1,496

1,106

1,176

910

326

33

30

35

38

30

46

48

215

160

120

94

66

80

257

165

172

167

162

166

173

165

135

123

129

145

134

133

140

125

111

135

204

314

367

Other expenses

-42

-

-

-

-

-

-

24

-

-

-

-

-

-124

9

-425

10,442

-2

-59

351

121

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

-

-

0

5

Realized loss on foreign currency transactions

-5

-

-1

-3

-13

-

-1

-2

-5

-

-18

4

-444

-

-179

-1,486

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

0

Total other expense, net

-7,301

50,376

-4,168

-3,883

-4,941

-4,165

-4,240

-4,482

-5,176

-4,933

-4,168

-5,421

-4,549

-2,787

-4,537

-5,896

6,934

-3,216

-3,976

-3,565

-3,864

-3,861

-4,340

-261

80

-119

-382

-583

-418

-226

-238

-233

-637

-84

-813

-1,143

-996

-445

-825

-1,059

-1,010

-429

-1,133

Loss before taxes

-13,470

64,862

-263,518

-27,272

-48,320

-53,465

24,057

54,553

-4,722

-223,011

-6,327

-2,725

-19,822

-2,073

-10,009

-19,929

-10,257

654

21,711

2,127

-5,123

-2,694

16,489

10,718

3,496

12,630

10,990

8,157

-2,914

1,098

10,127

4,825

8,218

12,943

19,853

-223

-555

3,672

12,438

-6,764

-21,115

-

-

Benefit from income taxes

-7,000

-802

20

200

-700

-63,136

38,000

8,400

3,477

-51,947

18,868

5,471

-918

1,021

3,023

-972

-9,737

-8,551

17,770

1,130

-2,038

-3,025

4,536

6,033

2,793

6,437

3,513

4,247

-1,775

-131,875

533

280

372

248

986

62

117

-

0

0

0

-

-

Net loss

-

-

-

-

-

-

-

-

-8,199

-

-

-

-

-

-13,032

-18,957

-

-

3,941

997

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) attributable to non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-307

-678

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-6,472

65,660

-263,535

-27,486

-47,605

-

-13,911

46,197

-

-171,064

-25,195

-8,196

-18,904

-3,094

-12,725

-18,279

-520

9,205

3,941

997

-3,085

331

11,953

4,685

703

6,193

7,477

3,910

-1,139

132,973

9,594

4,545

7,846

12,695

18,867

-285

-672

3,672

12,438

-6,764

-21,115

-19,429

-23,328

Net loss per sharebasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-0.41

-

-0.28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.62

Weighted average common shares outstanding used in computing net loss per sharebasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

45,808

-

45,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,708

Net loss per share—basic

-0.14

1.38

-5.55

-0.58

-1.00

0.20

-0.29

0.99

-0.18

-

-0.55

-0.18

-

-

-

-0.40

-0.01

0.22

0.09

0.02

-0.07

0.01

0.29

0.11

0.02

0.15

0.19

0.10

-0.03

3.37

0.24

0.12

0.20

0.33

0.48

-0.01

-0.02

0.11

0.32

-0.18

-0.56

-0.51

-

Net loss per share—diluted

-0.14

1.38

-5.55

-0.58

-1.00

0.20

-0.29

0.98

-0.18

-

-0.55

-0.18

-

-

-

-0.40

-0.01

0.21

0.09

0.02

-0.07

0.01

0.28

0.11

0.02

0.15

0.18

0.09

-0.03

3.30

0.24

0.11

0.19

0.32

0.47

-0.01

-0.02

0.12

0.31

-0.18

-0.56

-0.51

-

Weighted average common shares outstanding used in computing net loss per share—basic

47,703

47,579

47,511

47,486

47,472

47,528

47,184

46,799

46,529

-

46,002

45,943

-

-

-

45,338

44,815

42,630

42,174

42,085

42,031

41,540

41,094

41,032

40,934

40,725

40,315

39,960

39,832

39,600

39,463

39,433

39,340

39,182

39,100

38,937

38,781

115,322

38

38

38,021

37,749

-

Weighted average common shares outstanding used in computing net loss per share—diluted

47,703

47,579

47,511

47,486

47,472

48,450

47,184

47,201

46,529

-

46,002

45,943

-

-

-

45,338

44,815

45,739

43,432

43,282

42,031

43,144

42,365

42,432

42,235

43,317

41,996

41,583

39,832

40,663

40,159

40,099

40,407

42,364

40,174

38,937

38,781

115,320

39

38

38,021

37,749

-

Net Product Revenues
Total net revenues

24,672

47,411

44,800

47,191

41,334

66,351

139,973

150,412

103,003

170,043

134,357

132,756

112,593

134,007

128,508

120,695

110,148

123,716

141,330

107,565

93,500

110,629

98,481

89,719

74,463

86,348

79,760

80,125

64,084

75,390

72,206

69,112

65,673

69,048

65,420

62,878

58,925

64,412

61,265

40,478

15,390

12,857

12,549

Royalty Revenues
Total net revenues

3,427

3,085

2,922

2,862

2,803

2,801

2,841

2,890

3,162

16,091

4,444

4,418

4,528

4,354

4,841

4,499

3,492

4,922

4,605

3,878

4,087

4,978

5,216

5,146

3,791

-

2,895

-

-

-

2,967

4,280

3,310

1,332

347

134

96

-

0

-

-

-

-

License Revenue
Total net revenues

-

-

-

-

-

-

-

-

-

2,264

2,264

2,264

2,265

2,265

2,264

2,264

2,264

2,265

2,264

2,264

2,264

2,265

2,264

2,264

2,264

2,264

2,264

2,264

2,265

2,264

2,264

2,264

2,265

2,264

2,264

2,264

2,265

2,357

2,357

2,357

2,357

2,357

0